RGD density along with substrate stiffness regulate hPSC hepatocyte functionality through YAP signalling

Biomaterials. 2023 Feb:293:121982. doi: 10.1016/j.biomaterials.2022.121982. Epub 2022 Dec 22.

Abstract

Human pluripotent stem cell-derived hepatocytes (hPSC-Heps) may be suitable for treating liver diseases, but differentiation protocols often fail to yield adult-like cells. We hypothesised that replicating healthy liver niche biochemical and biophysical cues would produce hepatocytes with desired metabolic functionality. Using 2D synthetic hydrogels which independently control mechanical properties and biochemical cues, we found that culturing hPSC-Heps on surfaces matching the stiffness of fibrotic liver tissue upregulated expression of genes for RGD-binding integrins, and increased expression of YAP/TAZ and their transcriptional targets. Alternatively, culture on soft, healthy liver-like substrates drove increases in cytochrome p450 activity and ureagenesis. Knockdown of ITGB1 or reducing RGD-motif-containing peptide concentration in stiff hydrogels reduced YAP activity and improved metabolic functionality; however, on soft substrates, reducing RGD concentration had the opposite effect. Furthermore, targeting YAP activity with verteporfin or forskolin increased cytochrome p450 activity, with forskolin dramatically enhancing urea synthesis. hPSC-Heps could also be successfully encapsulated within RGD peptide-containing hydrogels without negatively impacting hepatic functionality, and compared to 2D cultures, 3D cultured hPSC-Heps secreted significantly less fetal liver-associated alpha-fetoprotein, suggesting furthered differentiation. Our platform overcomes technical hurdles in replicating the liver niche, and allowed us to identify a role for YAP/TAZ-mediated mechanosensing in hPSC-Hep differentiation.

Keywords: Hepatocyte; Hydrogel; Induced pluripotent stem cell; Mechano sensing; YAP.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Colforsin / metabolism
  • Colforsin / pharmacology
  • Cytochrome P-450 Enzyme System / metabolism
  • Cytochrome P-450 Enzyme System / pharmacology
  • Hepatocytes*
  • Humans
  • Hydrogels / chemistry
  • Oligopeptides* / metabolism
  • Oligopeptides* / pharmacology

Substances

  • arginyl-glycyl-aspartic acid
  • Colforsin
  • Oligopeptides
  • Cytochrome P-450 Enzyme System
  • Hydrogels